Total Payments
$1,305
2024 Payments
$75.25
Companies
12
Transactions
21
Medicare Patients
89
Medicare Billing
$8,445

Payment Breakdown by Category

Food & Beverage$1,147 (87.9%)
Education$157.98 (12.1%)
Other$0.00 (0.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $1,147 19 87.9%
Education $157.98 2 12.1%

Top Paying Companies

Company Total Records Latest Year
AstraZeneca Pharmaceuticals LP $438.56 6 $0 (2022)
Medtronic, Inc. $134.59 1 $0 (2023)
CSL Behring $122.55 1 $0 (2022)
Eisai Inc. $117.66 2 $0 (2024)
Kyowa Kirin, Inc. $106.27 1 $0 (2022)
GENZYME CORPORATION $94.89 1 $0 (2022)
Neurelis, Inc. $91.85 2 $0 (2021)
Chiesi USA, Inc. $91.57 1 $0 (2023)
UCB, Inc. $61.74 3 $0 (2024)
UPSHER-SMITH LABORATORIES LLC $16.25 1 $0 (2021)

Payment History by Year

Year Amount Transactions Top Company
2024 $75.25 4 Eisai Inc. ($28.05)
2023 $359.81 5 Medtronic, Inc. ($134.59)
2022 $544.66 6 AstraZeneca Pharmaceuticals LP ($220.95)
2021 $251.47 5 AstraZeneca Pharmaceuticals LP ($217.61)
2020 $74.24 1 Neurelis, Inc. ($74.24)

All Payment Transactions

21 individual payment records from CMS Open Payments

Date Company Product Nature Form Amount Type
11/11/2024 Eisai Inc. Leqembi (Drug) Food and Beverage In-kind items and services $28.05 General
Category: Neurology
10/24/2024 Azurity Pharmaceuticals, Inc. HORIZANT (Drug) Food and Beverage In-kind items and services $14.95 General
Category: CEREBROVASCULARCNS
10/10/2024 UCB, Inc. Briviact (Drug) Food and Beverage In-kind items and services $17.70 General
Category: Neurology
10/09/2024 Neurocrine Biosciences, Inc. INGREZZA (Drug) Food and Beverage In-kind items and services $14.55 General
Category: Neuropsychiatry
09/09/2023 Eisai Inc. Food and Beverage Cash or cash equivalent $89.61 General
08/22/2023 UCB, Inc. Fintepla (Drug) Food and Beverage In-kind items and services $15.32 General
Category: Neurology
08/08/2023 Medtronic, Inc. LINQ II (Device) Food and Beverage In-kind items and services $134.59 General
Category: Cardiac Diagnostics and Monitoring
06/02/2023 UCB, Inc. Fintepla (Drug) Food and Beverage In-kind items and services $28.72 General
Category: Neurology
05/17/2023 Chiesi USA, Inc. CLEVIPREX (Drug) Food and Beverage Cash or cash equivalent $91.57 General
Category: CARDIOVASCULAR
05/26/2022 CSL Behring Hizentra (Biological) Food and Beverage In-kind items and services $122.55 General
Category: Immunology
04/11/2022 GENZYME CORPORATION Food and Beverage In-kind items and services $94.89 General
03/31/2022 AstraZeneca Pharmaceuticals LP Education In-kind items and services $79.99 General
03/31/2022 AstraZeneca Pharmaceuticals LP BRILINTA (Drug) Food and Beverage In-kind items and services $15.96 General
Category: Cardiovascular and Metabolism
03/29/2022 Kyowa Kirin, Inc. NOURIANZ (Drug) Food and Beverage In-kind items and services $106.27 General
Category: Adenosine A2A Receptors
02/24/2022 AstraZeneca Pharmaceuticals LP BRILINTA (Drug) Food and Beverage In-kind items and services $125.00 General
Category: Cardiovascular and Metabolism
10/05/2021 AstraZeneca Pharmaceuticals LP Education In-kind items and services $77.99 General
10/05/2021 AstraZeneca Pharmaceuticals LP BRILINTA (Drug) Food and Beverage In-kind items and services $13.62 General
Category: Cardiovascular and Metabolism
09/16/2021 UPSHER-SMITH LABORATORIES LLC VIGADRONE (Drug) Food and Beverage In-kind items and services $16.25 General
Category: NEUROLOGY
07/29/2021 AstraZeneca Pharmaceuticals LP BRILINTA (Drug) Food and Beverage In-kind items and services $126.00 General
Category: Cardiovascular and Metabolism
05/27/2021 Neurelis, Inc. VALTOCO (Drug) Food and Beverage In-kind items and services $17.61 General
Category: EPILEPSY
11/19/2020 Neurelis, Inc. VALTOCO (Drug) Food and Beverage In-kind items and services $74.24 General
Category: EPILEPSY

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 4 89 114 $35,500 $8,445
Total Patients
89
Total Services
114
Medicare Billing
$8,445
Procedure Codes
4

All Medicare Procedures & Services

4 procedure records from CMS Medicare Utilization

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99232 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes Facility 2023 29 44 $10,120 $2,633 26.0%
99233 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes Facility 2023 17 26 $9,100 $2,271 25.0%
99222 Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes Facility 2023 21 22 $9,350 $2,163 23.1%
99221 Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes Facility 2023 22 22 $6,930 $1,377 19.9%

About Ramit Singla

Ramit Singla is a Student in an Organized Health Care Education/Training Program healthcare provider based in Columbia, South Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/30/2017. The National Provider Identifier (NPI) number assigned to this provider is 1427586908.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Ramit Singla has received a total of $1,305 in payments from pharmaceutical and medical device companies, with $75.25 received in 2024. These payments were reported across 21 transactions from 12 companies. The most common payment nature is "Food and Beverage" ($1,147).

As a Medicare-enrolled provider, Singla has provided services to 89 Medicare beneficiaries, totaling 114 services with total Medicare billing of $8,445. Data is available for 1 year (2023–2023), covering 4 distinct procedure/service records.

Practice Information

Products in Payments

  • BRILINTA (Drug) $280.58
  • LINQ II (Device) $134.59
  • Hizentra (Biological) $122.55
  • NOURIANZ (Drug) $106.27
  • VALTOCO (Drug) $91.85
  • CLEVIPREX (Drug) $91.57
  • Fintepla (Drug) $44.04
  • Leqembi (Drug) $28.05
  • Briviact (Drug) $17.70
  • VIGADRONE (Drug) $16.25
  • HORIZANT (Drug) $14.95
  • INGREZZA (Drug) $14.55

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Student in an Organized Health Care Education/Training Program Doctors in Columbia